Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07831213) titled 'Post-Market Clinical Follow-up (PMCF) Study of Safety and Performance of 300-01 RefillHA Lips' on Sept. 15.

Study Type: Observational

Primary Sponsor: Glyance

Condition: Mild Defects of the Lips

Recruitment Status: Recruiting

Date of First Enrollment: January 18, 2024

Target Sample Size: 87

Countries of Recruitment: Israel

To know more, visit https://clinicaltrials.gov/study/NCT07831213

Published by HT Digital Content Services with permission from Health Daily Digest....